Compare StocksCVS vs INTU

CVS Health Corporation (CVS) vs Intuit Inc. (INTU)

CVS
CVS Health Corporation
$71.86
VS
INTU
Intuit Inc.
$455.24

Rewards

CVS
  • Management has timed buybacks well — 2 out of 3 years showed value-accretive repurchases.
  • FCF yield of 8.5% is historically attractive — the business generates significant cash relative to its price.
  • PEG ratio of 0.67 suggests the stock is undervalued relative to its growth rate — paying less than 1x for each unit of earnings growth.
INTU
  • Gross margin of 80.9% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Intuit Inc. scores 79/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Free cash flow has grown at a 18.5% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

CVS
  • Gross margin of 13.3% is low, suggesting a competitive or commodity-like market with limited pricing power.
  • Trailing P/E of 51.7x is 89% above the historical average of 27.4x — the stock trades at a premium to its own history.
  • Net debt/EBITDA of 4.7x indicates heavy leverage — it would take over 4 years of EBITDA to pay off net debt.
INTU
  • 24 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.

Key Valuation Metrics

Learn more →
CVS
INTU
Valuation
$7.81B
Free Cash Flow
$5.30B
8.54%
FCF Yield
4.18%
51.70
Trailing P/E
29.58
8.79
Forward P/E
17.19
Quality & Moat
3.20%
ROIC
N/A
2.35%
ROE
N/A
13.29%
Gross Margin
80.90%
0.67
PEG Ratio
N/A
Balance Sheet Safety
1.06
Debt / Equity
N/A
N/A
Interest Coverage
No debt
4.74
Net Debt / EBITDA
0.00
3.70%
Dividend Yield
1.02%
CVS: 4INTU: 3
CVSINTU

Historical Fundamentals

Learn more →
CVS

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

INTU

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

$1 Retained Earnings Test

Learn more →
CVS
$-4.20
created per $1 retained over 3 years
Market Cap Declined
Σ Retained
$4.82B
Δ Market Cap
$-20.28B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
INTU
$12.31
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$6.10B
Δ Market Cap
+$75.17B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
CVS
Insufficient Data
Enter initial FCF to calculate intrinsic value
Current Price: $71.86
Fair Value: $0.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
INTU
5.8% Overvalued
Price is 5.8% above estimated fair value
Current Price: $455.24
Fair Value: $430.46
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
CVS

What growth rate is the market pricing in at $72?

+28.6%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.1%

The market implies +28.6% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.1%, reflecting heavy growth investment.

INTU

What growth rate is the market pricing in at $455?

+14.4%
Market-Implied Owner Earnings Growth
Standard FCF implies +10.1%

The market implies +14.4% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +10.1%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
CVS
46/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
INTU
79/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. ROIC Consistency is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
CVS
-2.54
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
INTU
-2.65
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
CVS
Insiders 1.1%Institutions 90.8%Retail & Other 8.1%
No. of Institutional Holders2,496
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
INTU
Insiders 2.4%Institutions 90.6%Retail & Other 7.1%
No. of Institutional Holders3,066
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
CVS
0
Buys (3M)
1
Buys (12M)
Total value (12M): $100,009
SANSONE GUY P
Director
$100,009
@ $63.70 · 2025-06-05
MAHONEY MICHAEL F
Director
$2.00M
@ $66.70 · 2025-02-18
NELSON STEVEN H
Officer
$1,289
@ $53.71 · 2025-01-23
CAPOZZI HEIDI B
Officer
$4,589
@ $57.36 · 2024-10-23
LUDWIG EDWARD J.
Director
$53,879
@ $53.88 · 2024-05-02
MAHONEY MICHAEL F
Director
$500,294
@ $54.49 · 2024-05-02
Open market purchases · includes direct & indirect ownership · excludes option exercises
INTU
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
CVS
0
Sells (3M)
0
Sells (12M)
CLARK JAMES DAVID
Officer
$498,488
@ $66.35 · 2025-03-05
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
INTU
2
Sells (3M)
24
Sells (12M)
Total value (12M): $121.78M
DALZELL RICHARD L
Director
$457,046
@ $457.50 · 2026-03-12
AUJLA SANDEEP S
Chief Financial Officer
$840,097
@ $629.76 · 2026-01-05
AUJLA SANDEEP S
Chief Financial Officer
$741,172
@ $675.02 · 2025-12-19
DALZELL RICHARD L
Director
$219,763
@ $659.95 · 2025-12-11
DALZELL RICHARD L
Director
$435,354
@ $653.68 · 2025-12-10
AUJLA SANDEEP S
Chief Financial Officer
$792,160
@ $677.06 · 2025-10-03
DALZELL RICHARD L
Director
$665,951
@ $666.62 · 2025-09-11
AUJLA SANDEEP S
Chief Financial Officer
$27,930
@ $665.00 · 2025-08-25
DALZELL RICHARD L
Director
$255,887
@ $768.43 · 2025-07-10
DALZELL RICHARD L
Director
$521,891
@ $783.62 · 2025-07-09
BALAZS ALEX G
Chief Technology Officer
$689,400
@ $782.52 · 2025-07-08
AUJLA SANDEEP S
Chief Financial Officer
$2.03M
@ $782.22 · 2025-07-03
NOTARAINNI MARK PHILLIP
Officer
$887,583
@ $774.51 · 2025-07-02
AUJLA SANDEEP S
Chief Financial Officer
$1.25M
@ $773.90 · 2025-07-02
HOTZ LAUREN DALE
Officer
$1.36M
@ $784.24 · 2025-06-27
BALAZS ALEX G
Chief Technology Officer
$1.12M
@ $771.24 · 2025-06-05
TESSEL MARIANNA
Officer
$26.12M
@ $760.84 · 2025-06-03
FENNELL LAURA A
Officer
$19.29M
@ $752.25 · 2025-05-29
FENNELL LAURA A
Officer
$30.46M
@ $738.61 · 2025-05-28
NOTARAINNI MARK PHILLIP
Officer
$340,143
@ $725.25 · 2025-05-27
AUJLA SANDEEP S
Chief Financial Officer
$11.66M
@ $726.15 · 2025-05-27
MCLEAN KERRY JEAN
General Counsel
$12.18M
@ $729.16 · 2025-05-27
FENNELL LAURA A
Officer
$5.00M
@ $612.45 · 2025-03-24
TESSEL MARIANNA
Officer
$4.43M
@ $600.13 · 2025-03-21
BURTON EVE B
Director
$1.02M
@ $600.00 · 2025-03-20
HOTZ LAUREN DALE
Officer
$667,838
@ $619.52 · 2025-01-10
AUJLA SANDEEP S
Chief Financial Officer
$814,350
@ $626.42 · 2025-01-08
FENNELL LAURA A
Officer
$2.94M
@ $613.70 · 2025-01-07
NOTARAINNI MARK PHILLIP
Officer
$228,121
@ $630.17 · 2025-01-03
AUJLA SANDEEP S
Chief Financial Officer
$68,506
@ $628.50 · 2025-01-03
BALAZS ALEX G
Chief Technology Officer
$15.86M
@ $665.98 · 2024-12-12
FENNELL LAURA A
Officer
$5.06M
@ $657.64 · 2024-12-10
MCLEAN KERRY JEAN
General Counsel
$11.16M
@ $650.78 · 2024-12-09
NOTARAINNI MARK PHILLIP
Officer
$6.21M
@ $646.47 · 2024-12-05
NOTARAINNI MARK PHILLIP
Officer
$2.36M
@ $646.83 · 2024-12-05
AUJLA SANDEEP S
Chief Financial Officer
$2.47M
@ $617.42 · 2024-10-10
AUJLA SANDEEP S
Chief Financial Officer
$466,015
@ $601.31 · 2024-10-03
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
CVS
FearGreed
😐Neutral(45/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
INTU
FearGreed
😐Neutral(41/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
CVS
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (45)
INTU
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (41)
View CVS Full AnalysisView INTU Full Analysis
CVS Health Corporation (CVS) vs Intuit Inc. (INTU) Stock Comparison | SafetyMargin.io